Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity

Journal article

Stewart H. et al, (2023), iScience, 26, 108080 - 108080

Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins

Journal article

Lu Y. et al, (2022), Frontiers in Microbiology, 13

Vaccinia virus BTB-Kelch proteins C2 and F3 inhibit NF-κB activation

Journal article

Zhang R-Y. et al, (2022), Journal of General Virology, 103

Selective modulation of cell surface proteins during vaccinia infection: A resource for identifying viral immune evasion strategies

Journal article

Depierreux DM. et al, (2022), PLOS Pathogens, 18, e1010612 - e1010612

Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase

Journal article

Linville AC. et al, (2022), Journal of Virology, 96

Poxviruses and paramyxoviruses use a conserved mechanism of STAT1 antagonism to inhibit interferon signaling

Journal article

Talbot-Cooper C. et al, (2022), Cell Host & Microbe, 30, 357 - 372.e11

The actin nucleator Spir-1 is a virus restriction factor that promotes innate immune signalling

Journal article

Torres AA. et al, (2022), PLOS Pathogens, 18, e1010277 - e1010277

DDX50 Is a Viral Restriction Factor That Enhances IRF3 Activation

Journal article

Pallett M. et al, (2022), Viruses, 14, 316 - 316

Load More